Subscribe To
FBIO / Fortress Biotech (FBIO) Reports Q1 Loss, Lags Revenue Estimates
FBIO News
By GlobeNewsWire
September 7, 2023
Fortress Biotech to Present at H.C. Wainwright 25th Annual Global Investment Conference
MIAMI, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on e more_horizontal
By GlobeNewsWire
May 19, 2023
Journey Medical Corporation to Announce First Quarter 2023 Financial Results on May 22, 2023
Company to host conference call to discuss financial results and provide a corporate update on May 22, 2023 at 4:30 p.m. ET Company to host conference more_horizontal
By Zacks Investment Research
May 15, 2023
Fortress Biotech (FBIO) Reports Q1 Loss, Lags Revenue Estimates
Fortress Biotech (FBIO) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to los more_horizontal
By GlobeNewsWire
March 22, 2023
Journey Medical Corporation to Announce Year End 2022 Financial Results on March 29, 2023
Company to host conference call to discuss financial results and provide a corporate update on March 29, 2023 at 4:30 p.m. ET Company to host conferen more_horizontal
By GlobeNewsWire
May 18, 2022
Fortress Biotech to Participate in Two Upcoming May 2022 Investor Conferences
MIAMI, May 18, 2022 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on eff more_horizontal